Schonfeld Strategic Advisors LLC
Position in AMLX — Amylyx Pharmaceuticals, Inc.
CIK 1665241
NEW YORK, NY
Position in AMLX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,081,336
+$827,028 QoQ
Shares Held
77,794
+269.5% QoQ
Ownership
0.070%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2022
13 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMLX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Schonfeld Strategic Advisors LLC holds $50,240,980 across 18 Drug Manufacturers - Specialty & Generic names. AMLX ranks #10 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ANIP |
Ani Pharmaceuticals Inc
|
185,629 | $14,274,870 | |
| 2 | BCRX |
Biocryst Pharmaceuticals Inc
|
1,337,693 | $12,734,837 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
56,615 | $7,458,460 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
4,290 | $2,543,884 | |
| 5 | SUPN |
Supernus Pharmaceuticals, Inc.
|
48,765 | $2,520,662 | |
| 6 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
43,599 | $2,099,291 | |
| 7 | ZTS |
Zoetis Inc.
|
16,271 | $1,923,394 | |
| 8 | XERS |
Xeris Biopharma Holdings, Inc.
|
296,431 | $1,719,299 |
All Filings in AMLX
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,081,336 | 77,794 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $254,308 | 21,052 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $593,026 | 43,637 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $4,143,699 | 646,443 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $414,675 | 117,140 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $733,059 | 193,931 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $539,229 | 166,429 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $41,040 | 21,600 | Shares | Sole | 2024-08-14 | |
| 2023-09-30 | $2,518,046 | 137,523 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $4,538,004 | 210,385 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $8,362,046 | 285,005 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $4,135,591 | 111,924 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $9,168,455 | 325,700 | Shares | Sole | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||